Your browser doesn't support javascript.
loading
Influence of Intravitreal Injection of Ranibizumab on Visual Acuity and GAS6,SDF-1 and VEGF in Serum of Patients with Proliferative Diabetic Retinopathy Lesions / 中国药房
China Pharmacy ; (12): 3700-3702, 2015.
Article em Zh | WPRIM | ID: wpr-502634
Biblioteca responsável: WPRO
ABSTRACT
OBJECTIVE:To investigate the effect of intravitreal injection of ranibizumab on visual acuity and GAS6,SDF-1 and VEGF levels in serum of patients with proliferative diabetic retinopathy lesions. METHODS:56 patients diagnosed as prolifera-tive diabetic retinopathy in our hospital during Mar. 2012 to Mar. 2014 were analyzed retrospectively and divided into simple lateral eyes group(29 cases)and bilateral eyes group(27 cases). All patients received single intravitreal injection of ranibizumab. The se-rum levels of GAS6,SDF-1 and VEGF were detected before treatment and 1,4 and 8 weeks after treatment. The visual acuity of patients were detected before treatment and 1 week after treatment. RESULTS:1,4 and 8 weeks after treatment,the serum levels of GAS6,SDF-1 and VEGF in 2 groups were decreased significantly,with statistical significance(P0.05). 1 week after treatment,the number of letter which had been seen by patient’s BC-VA were increased,compared to before treatment,with statistical significance(P0.05). CONCLUSIONS:Intravitreal injection of ranibizumab can improve visual acuity of patients with pro-liferative diabetic retinopathy.
Palavras-chave
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: China Pharmacy Ano de publicação: 2015 Tipo de documento: Article
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: China Pharmacy Ano de publicação: 2015 Tipo de documento: Article